|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Nov 05 '24 | Option Exercise | 18.80 | 96,986 | 1,823,337 | 595,931 | Nov 07 07:44 PM |
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Nov 05 '24 | Sale | 35.00 | 96,986 | 3,394,510 | 498,945 | Nov 07 07:44 PM |
EXEL | DANA T AFTAB | Officer | Nov 05 '24 | Proposed Sale | 35.00 | 96,986 | 3,394,510 | Nov 05 04:23 PM | |
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Oct 30 '24 | Sale | 31.40 | 1,162 | 36,487 | 498,945 | Nov 01 06:43 PM |
EXEL | DANA T AFTAB | Officer | Oct 30 '24 | Proposed Sale | 31.40 | 1,162 | 36,487 | Oct 30 04:10 PM | |
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Aug 12 '24 | Sale | 27.06 | 20,883 | 565,094 | 500,107 | Aug 14 07:12 PM |
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Aug 07 '24 | Option Exercise | 24.41 | 95,000 | 2,318,950 | 615,990 | Aug 09 07:32 PM |
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Aug 07 '24 | Sale | 25.00 | 95,000 | 2,375,000 | 520,990 | Aug 09 07:32 PM |
EXEL | Aftab Dana | Officer | Aug 09 '24 | Proposed Sale | 27.25 | 20,883 | 569,062 | Aug 09 05:18 PM | |
EXEL | DANA T AFTAB | Officer | Aug 07 '24 | Proposed Sale | 25.00 | 95,000 | 2,375,000 | Aug 07 04:17 PM | |
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Aug 30 '23 | Sale | 22.47 | 4,600 | 103,362 | 399,943 | Sep 01 08:15 PM |
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Feb 27 '23 | Option Exercise | 14.74 | 10 | 147 | 351,482 | Mar 01 07:56 PM |
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Feb 28 '23 | Option Exercise | 14.74 | 82,490 | 1,215,903 | 433,962 | Mar 01 07:56 PM |
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Feb 28 '23 | Sale | 17.50 | 82,490 | 1,443,575 | 351,472 | Mar 01 07:56 PM |
EXEL | Aftab Dana | CSO/EVP Disc & Trans Research | Feb 27 '23 | Sale | 17.50 | 10 | 175 | 351,472 | Mar 01 07:56 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite